Cellular Biochemistry of the Stepwise Development of Cancer with Chemicals: G. H. A. Clowes Memorial Lecture

Cancer Research

Volumn 44, Issue , 1984, Pages 5463-5474

  Farber, Emmanuel ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIMETHYLAMINO 3' METHYLAZOBENZENE; AZO DYE; CARBON TETRACHLORIDE; DIETHYLNITROSAMINE; DIMETHYLHYDRAZINE; ETHIONINE; FLUORENYLACETOHYDROXAMIC ACID; METHIONINE; N (2 FLUORENYL)ACETAMIDE; OROTIC ACID; PHENOBARBITAL;

ABSTRACT REPORT; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOLOGICAL MODEL; CHEMICAL CARCINOGENESIS; CYTOCHEMISTRY; CYTOLOGY; DIET; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESISTANCE; ETIOLOGY; HEREDITY; HISTOLOGY; IN VITRO STUDY; LIVER; LIVER CANCER; MODEL; NONBIOLOGICAL MODEL; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTIAL HEPATECTOMY; PRIORITY JOURNAL; RAT; REVIEW; SPLEEN;

ANIMAL; BIOTRANSFORMATION; CARCINOGENS; CELL DIVISION; CELL NUCLEUS; HUMAN; LIVER NEOPLASMS; MELANOMA; MODELS, BIOLOGICAL; NEOPLASMS; PRECANCEROUS CONDITIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0021750659     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (152)

1. Ahluwalla, M., and Farber, E. Alterations in glutathione status in early hyperplastic fiver nodules. Proc. Am. Assoc. Cancer Res., 25: 15. 1984.
2. Albino, A. P., Le Strange, R., Oliff, A. I., Furth, M. E., and Old, L. J. Transforming ras genes from human melanoma: a manifestation of tumor heterogeneity? Nature (Lond.). 308: 69-72. 1984.
3. Alpert, E., and Hirai, H. (eds.). Oncodevelopmental Biology and Medicine, pp. 1-459. New York: New York Academy of Sciences. 1983.
4. Astrom, A., De Pierre, J. W., and Ericksson, L. C. Characterization of drug-metabolizing systems in hyperplastic nodules from the fivers of rats receiving 2-acetytaminoflurene in their diet. Carcinogenesis (Lond.), 4: 577-581. 1983.
5. Babich, H. Butylated hydroxytoluene (BHT): a review. Environ. Res., 29: 1-29. 1982.
6. Bock, K. W., Lilienblum, W., Pfeil, H., and Eriksson, L. C. Increased uridine diphosphate-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res., 42: 3747-3752, 1982.
7. Cameron, R., Kellen, J., Kolin, A., Malkin, A., and Farter, E. 7-glutamyltrans-ferase in putative premafignant liver cel populations during hepatocarcino-genesis. Cancer Res., 38: 823-829, 1978.
8. Cameron, R., Sweeney, G. D., Jones, K., Lee, G., and Farter, E. A relative deficiency of cytochrome P-450 and aryl hydrocarbon [benzo(a)pyrene] hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat fiver. Cancer Res., 36: 3888-3893, 1976.
9. Cayama, E., Tsuda, H., Sarma, D. S. R., and Farter, E. Initiation of chemical carcinogenesis requires cell proliferation. Nature (Lond.), 275: 60-62, 1978.
10. Chasseaud, L. F. The role of glutathione and glutathione-S-transferase in the metabolism of chemical carcinogens and other electrophilic agents. Adv. Cancer Res., 29: 175-274, 1979.
11. Clerk, W. H., Jr., Elder, D. E., Guerry, D., Epstein, M. N., Greene, M. H., and Van Horn, M. A study of tumor progression. The precursor lesions of superficial spreading and nodular melanoma. Human Pathol., in press. 1984.
12. Columteno, A., Ledda, G. M., Rao, P. M., Rajalakshmi, S., and Sarma, D. S. R. Dietary orotic add, a new selective growth stimulus for carcinogen altered hepatocytes in rat. Cancer Lett., 16: 191-196, 1982.
13. Columbano, A., Rajalakshmi, S., and Sarma, D. S. R. Requirement of cell profiferation for the initiation of fiver carcinogenesis as assayed by three (different procedures. Cancer Res., 41: 2079-2083, 1981.
14. Conway, J. G., Popp, J. A., Ji, S., and Thurman, R. G. Effect of size on portal circulation of hepatic nodules from carcinogen-treated rats. Cancer Res., 43: 3374-3379, 1983.
15. Conway, J. G., Popp, J. A., and Thurman, R. G. Fluorescence of dye infused via the hepatic artery (H) and portal vein (P) in hepatic nodules from diethyl-nitrosamine-treated rats. Fed. Proc., 43: 590, 1984.
16. Craddock, V. M. Cell proliferation and experimental fiver cancer. In: H. M. Cameron, D. A. Linsell. and G. P. Warwick (eds.), Liver cell Cancer, pp. 152-201. Amsterdam: Elsevier Press. Inc., 1976.
17. deGeriache, J., Lans, M., Préet, V., Taper, H., and Roberfroid, M. Comparison of (different models of rat fiver carcinogenesis: conclusions from a systematic analysis. Toxicol. Pathol., in press, 1984.
18. de Gerlache, J., Lans, M., Taper, H., Pr6at, V., and Roberfold, M. Promotion of chemically initiated carcinogenesis. In: H. Vaino and M. Sorsa (eds.), Mutagens in Our Environment, pp. 35-46. New York: Alan R. Liss, Inc., 1982.
19. Demi, E., and Oesterie, D. Histochemical demonstration of enhanced glutathione content in enzyme-altered islands induced by carcinogens in rat fiver. Cancer Res., 40: 490-491, 1980.
20. Emmelot, P., and Scherer, E. The first relevant cell stage in rat fiver carcinogenesis. A quantitative approach. Biochim. Biophys. Acta, 605: 247-304, 1980.
21. Enomoto, K., and Farber, E. Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis. Cancer Res., 42: 2330-2335. 1982.
22. Epstein, S., Ito, N., Merkow, L., and Farber, E. Celular analysis of liver carcinogenesis: the induction of large hyperplastic nodules in the liver with 2-fluorenyiacetamide or ethionine and some aspects of their morphology and glycogen metaboism. Cancer Res., 27: 1702-1711, 1967.
23. Ericsson, L. C., Ahluwalia, M., Spiewak, J., Lee, G., Sarma, D. S. R., Roomi, M. W., and Farber, E. Distinctive biochemical pattern associated with resistance of hepatocytes in hepatocyte nodules during liver carcinogenesis. Environ. Health Perspect., 49: 171-174, 1983.
24. Ericsson, L. C., Sharma, R. N., Roomi, M. W., Ho, R. K., Farber, E., and Murray, R. K. A characteristic electrophoretic pattern of cytosolic polypeptides from hepatocyte nodules generated during liver carcinogenesis in several models. Biochem. Biophys. Res. Commun., 117: 740-745, 1983.
25. Ericsson, L. C., Tomdal, U.-B., and Andersson, G. N. Isolation and characterization of endoplasmic reticulum and Golgi apparatus from hepatocyte nodules in male Wistar rats. Cancer Res., 43: 3335-3347, 1983.
26. Farber, E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine. 2-aoetylaminofluorene and 3ʹ-methyl-4-dimethylaminoazobenzene. Cancer Res., 16: 142-148. 1956.
27. Farber, E. Ethionine carcinogenesis. Adv. Cancer Res., 7; 383-474, 1963.
28. Farber, E. Hyperplastic liver nodules. Methods Cancer Res., 7; 345-375, 1973.
29. Farber, E. The pathology of experimental liver cell cancer. In: H. M. Cameron, D. A. Linsel. and G. P. Warwick (eds.), Liver Cel Cancer, pp. 243-277. Amsterdam: Elsevier Press. Inc., 1976.
30. Farber, E. The sequential analysis of liver cancer induction. Biochim. Biophys. Acta. 605: 149-166, 1980.
31. Farber, E. Sequential events in chemical carcinogenesis. In: F. F. Becker (ed.). Cancer A Comprehensive Treatise, Ed. 2, Vol 1, pp. 485-506. New York: Plenum Publishing Corp., 1982.
32. Farber, E. Some emerging principles in the toxicological analysis of the combined effects of xenobiotics. In: H. F. Stoch, H. W. Leung, and J. R. Roberts, (eds.). Workshop on the Combined Effects of Xenobiotics. National Research Council of Canada. Publication 18978, pp. 237-253. Ottawa, Ontario, Canada: National Research Council of Canada, 1982.
33. Farber, E. The biology of carcinogen-induced hepatocyte nodules and related liver lesions in the rat. Toxicol. Pathol., 107: 197-205, 1982.
34. Farber, E. The biochemistry of preneoplastic liver a common metabolic pattern in hepatocyte nodules. Can. J. Biochem. Cel Biol., 62: 486-494, 1984.
35. Farber, E., and Cameron, R. The sequential analysis of cancer development. Adv. Cancer Res., 35: 125-226, 1980.
36. Farber, E., and Magee, P. N. The probable alkytation of liver ribonucleic add by the hepatic carcinogens dimethylnitrosamine and ethionine. Biochem. J., 76: 58 P., 1960.
37. Farber, E., Parker, S., and Gruenstein, M. The resistance of putative prema-lignant liver cell populations, hyperplastic nodules, to the acute cytotoxic effects of some hepatocarcinogens. Cancer Res., 36: 3879-3887, 1976.
38. Feo, F., Canuto, R. A., Garcaa, R., Brossa, O., and Caselli, G. C. Phenobarbital stimulation of cytochrome P-450 and aminopyrene N-demethylase in hyperplastic liver nodules during DL-ethionine carcinogenesis. Cancer Lett., 5: 25-30, 1978.
39. Fiala, S., Mohindru, A., Kettering, W. G., Rate, A. E., and Morris, H. P. Glutathione and gamma glutamyltranspeptidase in rat liver during chemical carcinogenesis. J. Natl. Cancer Inst., 57: 591-598, 1976.
40. Fidler, I. G., and Hart, I. R. Biological diversity in metastatic neoplasms: origins and implcations. Science (Wash. DC). 217: 998-1003, 1982.
41. Finkelstein, S., Lee, G., Medicine, A., Tatematsu, M., Makowka, L., and Farber, E. An experimental method for rapid growth of liver in spleen. The survival and proliferation of chemically induced preneoplastic hepatocytes in spleen. Am. J. Pathol., 110: 119-126, 1983.
42. Foulds, L. Neoplastic Development, Vols. 1-2. New York: Academic Press, Inc., 1969 and 1975.
43. Frankfurt, O. S., Lipchina, L. P., Bunto, T. V., and Emanuel, N. M. Vliianie 4-metl-2, 6-di-tert.-butilfenolo (ionolo) na induktsiu opukholei pecheni u krys. Blul. Eksp. Biol. Med., 64: 86-88, 1967.
44. Gans, J. H. Diethylnitrosamine-induced changes in mouse liver morphology and function. Proc. Soc. Exp. Biol. Med., 152: 116-120, 1976.
45. Ghoshal, A. K., and Farber, E. Induction of liver cancer by a diet deficient in choline and methionine (CMD). Proc. Am. Assoc. Cancer Res., 24: 98. 1983.
46. Goldfarb, S. A morphological and histochemical study of carcinogenesis of the liver in rats fed 3ʹ-methyl4ʹ'-dimethylaminoazobenzene. Cancer Res., 33: 1119-1128, 1973.
47. Gravela, E., Feo, F., Canuto, R. A., Garcea, R., and Gabriel, L. Functional and structural alterations of liver ergastoptasmic membranes during dl-ethionine hepatocardnogenesis. Cancer Res., 35: 3041-3047, 1975.
48. Haddow, A. Celular inhibition and the origin of cancer. Acta Unio Intern. Contra Cancrum, 3: 342-352, 1938.
49. Hayes, M. A. Failure of selective growth of liver nodules in rats given phenoberbitone during short-term feedhig of 2-acetylaminofluorene. Proc. Am. Assoc. Cancer Res., 24: 85, 1983.
50. Hayes, M. A., Cameron, R. G., Roberts, E., Safe, S., and Farber, E. Modulation of cytoddal and mitoinhibitory toxicity of hepatocardnogens in rats pretreated with different pure PCBs and other inducers. Proc. Am. Assoc. Cancer Res., 25: 128. 1984.
51. Heppner, G. H. Tumor heterogeneity. Cancer Res., 44: 2259-2265. 1984.
52. Hiasa, Y., Ohshima, M., Ohmori, T., and Murata, Y. Effect of alpha-benzene hexachloride on 2-fluorenytacetamide carcinogenesis in rats. Gann, 69: 423-426, 1978.
53. Ho, R. K., Mishkin, S., and Farber, E. Stimulation by progesterone and inhibition by estradiol of growth of liver nodules in recipient rats after intraportal transfer of hepatocytes from hyperplastic liver nodules. Proc. Am. Assoc. Cancer Res., 23: 52. 1982.
54. Ishidate, M., Watanabe, M., and Odashima, S. Effect of barbital on carcinogenic action and metabolism of 4-dimethylaminoazobenzene. Gann, 58: 267-281, 1967.
55. Ito, N., Fukushima, S., Tsuda, H., Shirai, T., Tatematsu, M., and Imrida, K. Modification of chemical carcinogenesis by antioxidants. In: H. Fujiki, E. Hesker, R. Moore, T. Sugimura, and I. B. Weinstein (eds.), Celular Interactions by Environmental Tumor Promoters. Fourteenth International Symposium of the Princess Takamatsu Cancer Research Fund, Tokyo, in press, 1984.
56. Ito, N., Nakanishi, K., Hagiwara, A., Shibata, M., and Fukushima, S. Induction of hyperplastic liver nodules by phenobarbital in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine. Gann. 71: 918-919. 1980.
57. Ito, N., Tatematsu, M., Nakanishi, K., Hosegawa, R., Takano, T., Imtida, K., and Ogiso, T. The effects of various chemicals on the development of hyperplastic liver nodules in hepatectomized rats treated with N-nitrosoethy-lamine or N-2-fluorenylaoetamide. Garm, 71: 832-842, 1980.
58. Jakoby, W. B. (ed.) Enzymatic Basis of Detoxification, Vol. 2. New York: Academic Press, Inc., 1980.
59. Judah, D. J., Legg, R. F., and Neal, G. E. Development of resistance to cytotoxicity during aflatoxin carcinogenesis. Nature (Lond.), 265: 343-345. 1977.
60. Kaneko, A., Dempo, K., Kaku, T., Yokoyama, S., Satoh, M., Mori, M., and Onoé, T. Effect of phenobarbital administration on hepatocytes constituting the hyperplastic nodules induced in rat liver by 3-methyi-4-dimethyiaminoa-zobenzene. Cancer Res., 40: 1658-1662, 1980.
61. Ketterer, B., Cdes, B., and Myer, D. J. The role of glutathione in detoxification. Environ. Hetfth Perspect., 49: 59-69, 1983.
62. Kinosita, R. Studtes on the carcinogenic chemical substances. Trans. Jpn. Pathol. Soc., 27: 665-729, 1937.
63. Kitagawa, T., Pitot, H. C., Mier, E. C., and Mier, J. A. Promotion by dietay phenobarbital of hepatocardnogenesis by 2-methyl-N, N-dimethyl-4-aminoa-zobenzene in the rat. Cancer Res., 39: 112-115, 1979.
64. Kitagawa, T., and Sugano, H. Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocelular carcinomas initiated by 3ʹ-nrethyl-4dimethylamino)azobenzene or diethyinitrosamine. Garm, 69: 679-687, 1978.
65. Kitahara, A., Satoh, K., Nishimura, K., Ishikawa, T., Ruike, K., Sato, K., Tsuda, H., and Ito, N. Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocardnogenesis. Cancer Res., 44: 2698-2703. 1984.
66. Kitahara, A., Satoh, K., and Sato, K. Properties of the increased glutathione S-transferase A form in rat preneoplastic hepatic lesions induced by chemical carcinogens. Biochem. Biophys. Res. Commun., 112: 20-28, 1983.
67. Kitahara, A., Yamazaki, T., IsNkawa, T., Camba, E. A., and Sato, K. Changes in activities of glutathione peroxidase and glutathione reductase during chemical hepatocardnogenesis in the rat. Gann, 74: 649-655. 1983.
68. Kunz, W., Schaude, G., and Thomas, C. Die Beeinfiuss der Nitrosamincardnogenese durch Phenobarbital und Halogenkohlenwasserstoffe. Z. Krebsforsch., 72: 291-301, 1969.
69. Laishes, B., Roberts, E., and Farber, E. In vitro measurement of carcinogen resistant liver cels during hepatocardnogenesis. Int. J. Cancer, 21: 186-193, 1978.
70. Laurier, C., Tatematsu, M., Rao, P. M., Rajalakshmi, S., and Sarma, D. S. R. Promotion by orotic add of liver carcinogenesis in rats initiated by 1, 2-dimethyttiydrazine. Cancer Res., 44: 2186-2191, 1984.
71. Le Beau, M. M., and Rowley, J. D. Heritable fragile sites in cancer. Nature (Lond.). 308: 607-608. 1984.
72. Ledda, G. M., Coiumbano, A., Nagarine, Y., Ho, R. K., Rao, P. M., Raja-lakshmi, S., and Sarma, D. S. R. Possible sites and mechanism of action of cel proliferation in experimental liver chemical carcinogenesis. In: P. Pani. F. Feo, and A. Coiumbano (eds.), Recent Trends in Chemical Carcinogenesis, Vol. 1, pp. 117-127. Cagliari, Italy: Edizioni Scientifiche Associate, 1983.
73. Lee, G., Medline, A., Finkelstein, S., Tatematsu, M., Makowka, L., and Farber, E. Transplantation of hepatocytes from normal and preneoplastic livers into spleens of syngeneic host rats. Transplantation (Baltimore), 36: 218-221, 1983.
74. Lee, G., Tatematsu, M., and Makowka, L. The development of hepatoceluiar carcinoma from carcinogen altered hepatocytes in the spleen. Identification of a new cell population with relevance to cancer. Proc. Am. Assoc. Cancer Res., 24: 106, 1983.
75. Lee, P. C., Bochner, B. R., and Ames, B. N. AppppA, heat shock stress and cell oxidation. Proc. Natl. Acad. Sci. USA, 80: 7496-7500, 1983.
76. Lind, C., Hochstein, P., and Ernster, L. DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation. Arch. Biochem. Biophys., 216: 178-185, 1982.
77. Makiura, S., Aloe, H., Sugihara, S., Hirao, K., Arai, M., and Ito, N. Inhibitory effects of polychlorinated biphenyls on liver tumorigenesis in rats treated with 3ʹ-metiiyl-4-dimethylaminoazobenzene and dtethyinitrosamine. J. Natl. Cancer Inst., 53: 1253-1257, 1974.
78. Marroquin, F., and Farber, E. The binding of 2-acetylaminofluorene to rat liver ribonucleic acid in vivo. Cancer Res., 25: 1262-1269, 1965.
79. McLean, A. E. M., and Marshall, A. Reduced carcinogenic effects of aflatoxin in rats give phenobarbitone. Br. J. Exp. Pathol., 52: 322-329, 1971.
80. Meister, A., and Anderson, M. E. Glutathione. Amu. Rev. Biochem., 52: 711-760, 1983.
81. Mikol, Y. B., Hoover, K. L., Creasia, D., and Poirier, L. A. Hepatocarcino-genesis in rats fed methyl-deficient amino acid-defined diets. Carcinogenesis (Lond.), 4: 1619-1629, 1983.
82. Mishkin, S. Y., Farber, E., Ho, R. K., Mulay, S., and Mishkin, S. Evidence for the hormonal dependence of hepatic hyperplastic nodules: inhibition of malignant transformation after exogenous 170-estradiol and tamoxifen. Hepatol-ogy (Baltimore), 3: 308-316, 1983.
83. Moore, M. A., Hacker, H. J., and Bannasch, P. Phenotypic instability in focal and nodular lesions in a short-term system in the rat liver. Carcinogenesis (Lond.), 4: 595-603, 1983.
84. Morris, H. P. Biological and biochemical characteristics of transplantable hepatomas. In: E. Grundmann (ed.), Handbuch der älgemeinen Pathologie, Vol. 6, Part 7, pp. 277-334. Berlin: Springer-Verlag, 1975.
85. Nachtomi, E., Lee, G., Cameron, R., and Farber, E. Superoxide dismutase and glutathione peroxidase activities in hepatocyte nodules generated in rats. Proc. Am. Assoc. Cancer Res., 25: 96, 1984.
86. Natria, T., Watanabe, R., and Kitagawa, T. Mechanisms of inhibition of simultaneously administered phenobarbital of 3ʹ-methyl-4-[dimethyla-mino)azobenzene-induced hepatocardnogenesis in the rat. Gann, 71: 755-758, 1980.
87. Nishizumi, M. Enhancement of dtethyinitrosamine hepatocardnogenesis in rats by exposure to polychlorinated biphenyls or phenobarbital. Cancer Lett., 2: 11-15, 1976.
88. Nishizumi, M. Effect of phenobarbital, dichloroiphenyltrichtoroethane and polychlorinated biphenyls on diethylnitrosamine-induced hepatocardnogenesis. Gann, 70: 835-837, 1979.
89. Nishizumi, M. Reduction of diethylnitrosamine-induced hepatoma in rats exposed to polychlorinated byphenyls through their dams. Gann, 71: 910-912, 1980.
90. Oesch, F. Drug detoxification: epoxide hydrolase. Progr. Clin. Biol. Res., 135: 81-105, 1983.
91. Ogawa, K., Medline, A., and Farber, E. Sequential analysis of hepatic carcinogenesis: the comparative architecture of preneoplastic, malignant, prenatal, postnatal and regenerating liver. Br. J. Cancer, 40: 782-790, 1979.
92. Ogawa, K., Medline, A., and Farber, E. Sequential analysis of hepatic carcinogenesis. A comparative study of the ultrastructure of preneoplastic, malignant, prenatal, postnatal and regenerating liver. Lab. Invest., 41: 22-35, 1979.
93. Ogawa, K., Solt, D. B., and Farber, E. Phenotypic diversity as an early property of putative preneoplastic hepatocyte populations in liver carcinogenesis. Cancer Res., 40: 725-733, 1980.
94. Okita, K., Noda, K., Fukumoto, Y., and Takemoto, T. Cytochrome P-450 in hyperplastic liver nodules during hepatocardnogenesis with N-2-fluorenyl-acetamide in rats. Gann, 67: 899-902, 1976.
95. Peraino, C., Fry, R. J. M., and Staffeldt, E. Reduction and enhancement by phenobarbital of hepatocardnogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res., 31: 1506-1512, 1971.
96. Peraino, C., Fry, R. J. M., Staffeldt, E., and Christopher, J. P. Enhancing effects of phenobarbitone and butyiated hydroxytoluene on 2-acetylaminoflu-orene-induced hepatic tumorigenesis in the rat. Food Cosmet. Toxicol., 15: 93-96, 1977.
97. Peraino, C., Fry, R. J. M., Staffeldt, E., and Kisieleski, W. E. Effects of varying the exposure to phenobarbital on Its enhancement of 2-acetytaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res., 33: 2701-2705, 1973.
98. Pereira, M. A., Herren, S. L., Butt, A. L., and Khoury, M. M. Promotion by polychlorinated biphenyls of enzyme-altered fod In rat liver. Cancer Lett., 15: 185-190, 1982.
99. Pitot, H. C., Barsness, L., Goldsworthy, T., and Kitagawa, T. Biochemical characterization of stages of hepatocardnogenesis after a single dose of dtethyinitrosamine. Nature (Lond.), 271: 456-458, 1978.
100. Pitot, H. C., and Sirica, A. E. The stages of initiation and promotion in hepatocardnogenesis. Biochim. Biophys. Acta, 605: 191-215, 1980.
101. Poirier, L. A., Mikol, Y. B., Hoover, K., and Creasia, D. Liver tumor formation in rats fed methyl-deficient, amino add-defined diets with and without dieth-ylnitrosamine initiation. Proc. Am. Assoc. Cancer Res., 24: 97, 1983.
102. Popper, H., de La Huerga, J., and Yesinick, C. Hepatic tumors due to prolonged ethionine feeding. Science (Wash. DC), 48: 80-82, 1953.
103. Popper, H., Sternberg, S. S., Oser, B. C., and Oser, M. The carcinogenic effect of aramite in rats. A study of hepatic nodules. Cancer (PhHa.), 13: 1035-1046, 1960.
104. Potter, V. R. Transplantable animal cancer, the primary standard. Cancer Res., 21: 1331-1333, 1961.
105. Potter, V. R. Biochemical perspectives in cancer research. Cancer Res., 24: 1085-1098, 1964.
106. Potter, V. R. Phenotypic diversity in experimental hepatomas: the concept of partially blocked ontogeny. Br. J. Cancer, 38: 1-23, 1978.
107. Potter, V. R. Alternate hypotheses for the rote of promotion in chemical carcinogenesis. Environ. Health Perspect., 50: 139-148, 1983.
108. Potter, V. R. Use of two sequential applications of initiators in the production of hepatomas in the rat an examination of the Solt-Farber protocol. Cancer Res., 44: 2733-2736, 1984.
109. Preát, V., de Gerlache, J., Lans, M., Taper, H., and Roberfroid, M. Biological analysis of the hepatocardnogenesis process: comparison of the effects of two nitrosamines and two promoters. Teratogen. Carcinogen. Mutagen., in press, 1984.
110. Pugh, T. D., and Gokldfarb, S. Quantitative histochemical and autoradiographic studies of hepatocardnogenesis in rats fed 2-acetylaminofluorene followed by phenobarbital. Cancer Res., 38: 4450-4457, 1978.
111. Rajalakshmi, S., Rao, P. M., and Sarma, D. S. R. Chemical carcinogenesis: interactions of carcinogens with nucleic adds. In: F. F. Becker (ed.), Cancer A Comprehensive Treatise, Ed. 2, Vol. 1, pp. 335-409. New York: Plenum Publishing Corp., 1982.
112. Rao, P. M., Nagamine, K., Ho, R. K., Roomi, M. W., Laurier, C., Rajalakshmi, S., and Sarma, D. S. R. Dietary orotic add enhances the incidence of y-glutamyl transferase positive fod in rat liver induced by chemical carcinogens. Carcinogenesis (Lond.), 4: 1541-1545, 1983.
113. Rappaport, A. M. Physioanatomicai basis of toxic liver injury. In: E. Farber and M. M. Fisher (eds.), Toxic Injury of the Liver, Part A, pp. 1-57. New York: Marcel Dekker, 1979.
114. Reuber, M. D. Development of preneoplastic and neoplastic lesions of the liver in mate rats given 0.025 percent N-2-fluorenylacetamide. J. Natl. Cancer Inst., 34: 697-723, 1965.
115. Roberts, E., Ahluwalia, M. B., Lee, G., Chan, C., Sarma, D. S. R., and Farber, E. Resistance to hepatotoxins acquired by hepatocytes during liver regeneration. Cancer Res., 43: 28-34, 1983.
116. Roomi, M. W., Ho, R. K., Cameron, R. G., Sarma, D. S. R., and Farber, E. A novel biochemical pattem in hepatocyte nodules generated during liver carcinogenesis in five different models. Proc. Am. Assoc. Cancer Res., 25: 112, 1984.
117. Rotstein, J., and Farber, E. The response of nodular livers to partial hepatec-tomy (PH) during the carcinogenic sequence. Proc. Am. Assoc. Cancer Res., 25: 148, 1984.
118. Sarma, D. S. R., Rajalakshmi, S., and Farber, E. Chemical carcinogenesis: interactions of carcinogens with nucleic adds. In: F. F. Becker (ed.), Cancer A Comprehensive Treatise, Ed. 1, Vol. 1, pp. 235-287. New York: Plenum Publishing Corp. 1975.
119. Sasaki, T., and Yoshida, T. Experimentelle Erzeugung des Lebercardnoms durch FÜtterung mit o-Amidoazotoluol. Virchow's Arch. Pathol. Anat. Physiol. Klin. Med., 295: 175-200, 1935.
120. Sato, K., Kitahara, A., Satoh, K., Ishikawa, T., Tatematsu, M., and Ito, N. The placental form of glutathione S-transferase as a new marker protein for preneoplasia in rat chemical hepatocardnogenesis. Gann, 75: 199-202, 1984.
121. Sato, K., Tsuchida, S., Waragai, F., Yin, Z., and Ebina, T. Properties of molecular forms of 7-glutamyl transpeptidase and uridine diphosphate-glu-curonyltransferase as hepatic preneoplastic marker enzymes. Garm Monogr., 29: 23-31, 1983.
122. Scherer, E., and Emmelot, P. Kinetics of evolution and growth of precancer-ous liver-cell fod and liver tumor formation by dtethyinitrosamine in the rat. Eur. J. Cancer, 11: 689-696, 1975.
123. Scherer, E., and Emmelot, P. Kinetics of induction and growth of enzyme-defident islands involved in hepatocardnogenesis. Cancer Res., 36: 2544-2554, 1976.
124. Scherer, E., Hoffmann, M., Emmelot, P., and Friedrich-Freksa, H. Quantitative study of fod of altered liver cells induced in the rat by a single dose of dtethyinitrosamine and partial hepatectomy. J. Natl. Cancer Inst., 49: 93106, 1972.
125. Schlesinger, M. J., Ashbumer, M., and Tissieres, A. (eds.). Heat Shock: From Bacteria to Man. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
126. Schulte-Hermann, R. Reactions of the liver to injury: adaptation. In: E. Farber and M. M. Fisher (eds.), Toxic Liver Injury, pp. 385-444. New York: Marcel Dekker, 1979.
127. Schulte-Hermann, R., Ohde, G., Schuppler, J., and Timmermann-Trosiener, I. Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocydohexane, steroid compounds, and nafenopin. Cancer Res., 41: 2556-2562, 1981.
128. Schulte-Hermann, R., and Parzefall, W. Failure to discriminate initiation from promotion of liver tumors in a long-term study with the phenobarbital-type inducer α-hexachlorocyclohexane and the role of sustained stimulation of hepatic growth and monooxygenases. Cancer Res., 41: 4140-4146, 1981.
129. Schulte-Hermann, R., Timmermann-Trosiener, I., and Schuppler, J. Aberrant adaptation to phenobarbital may cause selective growth of foci of altered cells in rat liver. The Role of Cocarcinogens and Promoters in Human and Experimental Carcinogenesis. IARC Sci. Publ., in press, 1984.
130. Sels, M. A., Katyal, S. L., Sell, S., Shinozuka, H., and Lombardi, B. Induction of foci of altered γ-glutamyl-transpeptidase positive hepatocytes in carcinogen treated rats fed a choline deficient diet. Br. J. Cancer, 40: 274-283, 1979.
131. Shinozuka, H., Sels, M. A., Katyal, S. L., Sel, S., and Lombardi, B. Effects of a choline-devoid diet on the emergence of 7-glutamyttranspeptidase-positive fod in the Kver of carcinogen-treated rats. Cancer Res., 39: 2515-2521, 1979.
132. Soft, D. B., and Farber, E. New principle for the analysis of chemical carcinogenesis. Nature (Lond.), 263: 702-703, 1976.
133. Soft, D. B., Hay, J. B., and Farber, E. Comparison of the blood supply to diethylnitrosamine-induced hyperplastic nodules and hepatomas and to the surrounding Kver. Cancer Res., 37: 1686-1691, 1977.
134. Sott, D. B., Medline, A., and Farber, E. Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am. J. Pathol., 88: 595-618, 1977.
135. Spiewak, J., and Eriksson, L. C. Pharmacokinetics of 2-acetylaminofluorene (2-AAF) excretion in normal rats and rats with 2-AAF-induoed nodules. Proc. Am. Assoc. Cancer Res., 24: 76, 1983.
136. Spiewak, J. A. The role of metaboism in rendering carcinogen-induced liver nodules resistant to the effects of 2-acetylaminofluorene (2-AAF). Proc. Am. Assoc. Cancer Res., 25; 113, 1984.
137. Takano, T., Tatematsu, M., Hosegawa, R., Imaida, K., and Ito, N. Dose-response relationship for the promoting effect of phenobarbital on the induction of Kver hyperplastic nodules in rats exposed to 2-fluorenytaoetamide and carbon tetrachloride. Garm, 71: 580-581, 1980.
138. Tatematsu, M., Murasaki, G., Nakanishi, K., Miyata, Y., Shinohara, Y., and Ito, N. Sequential quantitative studies in hyperplastic nodules in the Kver of rats treated with carcinogenic chemicals. Garm, 70: 125-130, 1979.
139. Tatematsu, M., Nagamine, Y., and Farber, E. RecHfferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing Kver. Cancer Res., 43: 5049-5058, 1983.
140. Tatematsu, M., Nakakanishi, G., Miyata, Y., Hirose, M., and Ito, N. Enhancing effect of inducers of Kver microsomal enzymes in induction of hyperplastic Kver nodules by N-2-fluorenylacetamide in rats. J. Natl. Cancer Inst., 63; 1411-1416, 1979.
141. Teebor, G. W., and Becker, F. F. Regression and persistence of hyperplastic hepatic nodules induced by N-2-fluorenytecetamide and their relationship to hepatocardnogenesis. Cancer Res., 31: 1-3, 1971.
142. Thamavit, W., Hiasa, Y., Ito, N., and Bhamarapravati, N. The inhibitory effects of α-benzene hexachloride on 3ʹ-methyl-4-dimethylaminoazobenzene and DL-ethionine carcinogenesis in rats. Cancer Res., 34: 337-340, 1974.
143. Tsuda, H., Lee, G., and Farber, E. Induction of resistant hepatocytes as a new principle for a possible short-term in vivo test for carcinogens. Cancer Res., 40: 1157-1164, 1980.
144. Uland, B. M., Weisburger, J. H., Yamamoto, R. S., and Weisburger, E. K. Antioxidants and carcinogenests: butylated hydroxytokiene, but not diphenyt-p-phenyienediamine, inhibits cancer induction by N-2-fiuorenylacetamide and by N-hydroxy-N-2-fluorenyiacetamide in rats. Food Cosmet. Toxicol., 11: 119-207, 1973.
145. Van der Heijden, C. A., and Dormans, J. A. M. A. Short-term induction of neoplastic nodules in the rat liver. II. Study of their development and effects of withdrawal of 2-acetylaminofluorene. Carcinogenesis (Lond.), 2; 147-156, 1981.
146. Van der Heijden, C. A., Dormans, J. A. M. A., and Van Nesselrooij, J. H. J. Short term induction of preneoplastic nodules in the rat liver. I. The role of 2-AAF as selecting agent. Eur. J. Cancer, 16: 1389-1398, 1980.
147. Warholm, M., Guthenberg, C., Mannervik, B., and von Bahr, C. Purification of a new glutathione S-transferase (transferase mu) from human liver having high affinity with benzo (alpha) pyrene-4, 5-oxide. Biochem. Biophys. Res. Commun., 98: 512-519, 1981.
148. Wattenberg, L. W. Inhibitors of chemical carcinogens. In: J. H. Burchenal (ed.). Cancer Achievements, Challenges and Prospects for the 1980ʹs, pp. 517-549. New York: Grune and Stratton, 1981.
149. Weisburger, J. H., Madison, R. M., Ward, J. M., Viguera, C., and Weisburger, E. K. Modification of dtethyinitrosamine Kver carcinogenesis with phénobarbital but not with immunosuppression. J. Natl. Cancer Inst., 54: 1185-1188, 1975.
150. Woodruff, M. F. A. Celular heterogeneity in tumors. Br. J. Cancer, 47: 589-594, 1983.
151. Ying, T. S., Enomoto, K., Sarma, D. S. R., and Farber, E. Effects of delays in the cell cycle on the induction of preneoplastic and neoplastic lesions in rat liver by 1, 2-dimethyliydrazine. Cancer Res., 42: 876-880, 1982.
152. Ying, T. S., Sarma, D. S. R., and Farber, E. Role of acute hepatic necrosis in the induction of early steps in liver carcinogenesis by dtethyinitrosamine. Cancer Res., 41: 2096-2102, 1981.